Company research / VXRT

Vaxart, Inc. (VXRT)

CIK 0000072444 · OTC · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, Vaxart, Inc. reported revenue of $237.26M. Revenue grew 726.7% from the prior annual period.

Key ratios (year ended 2025-12-31)

7.6%
Operating margin
6.9%
Net margin
18.6%
Return on year-end equity
726.7%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 8-K · 2026-08-25

Headquarters locality: San Francisco · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.